Mirum Pharmaceuticals (MIRM) Assets Average (2019 - 2026)

Mirum Pharmaceuticals' Assets Average history runs 8 years deep, the most recent figure standing at $866.9 million for Q1 2026.

• In Q1 2026, Assets Average rose 27.39% year-over-year to $866.9 million; the TTM figure through Mar 2026 stood at $866.9 million (up 27.39% YoY), while the FY2025 annual figure was $756.8 million, up 14.89% from the prior year.
• Assets Average was $866.9 million for Q1 2026 at Mirum Pharmaceuticals, up from $814.0 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $866.9 million in Q1 2026 to a low of $286.4 million in Q1 2022.
• Historically, Assets Average has averaged $568.0 million across 5 years, with a median of $649.3 million in 2024.
• Biggest YoY gain for Assets Average was 89.18% in 2024; the steepest drop was 3.19% in 2024.
• A 5-year view of Assets Average shows it stood at $358.6 million in 2022, then soared by 80.87% to $648.6 million in 2023, then gained by 3.19% to $669.3 million in 2024, then gained by 21.61% to $814.0 million in 2025, then climbed by 6.5% to $866.9 million in 2026.
• The last three Assets Average figures came in at $866.9 million (Q1 2026), $814.0 million (Q4 2025), and $755.5 million (Q3 2025), per Business Quant data.